#ESC2021 Hotline: Results from the FIGARO-DKD trial Effect of finerenone on cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes
#ESC2021 Hotline: Results from the FIGARO-DKD trial Effect of finerenone on cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes